Bibliography
- MCGIVERN JG, WORLEY JF: Ion channels: voltage gated. In: Comprehensive Medicinal Chemistry II. Triggle DJ et al. (Eds), Elsevier, Oxford, UK (2007):827-875.
- HODGKIN AL, HUXLEY AF: A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (1952) 117(4):500-544.
- HAMILL OP, MARTY A, NEHER E, SAKMANN B, SIGWORTH FJ: Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. (1981) 391(2):85-100.
- LONG SB, CAMPBELL EB, MACKINNON R: Crystal structure of a mammalian voltage-dependent Shaker family K+ channel. Science (2005) 309(5736):897-903.
- LEVITAN IB: Signaling protein complexes associated with neuronal ion channels. Nat. Neurosci. (2006) 9(3):305-310.
- KUBISCH C, SCHROEDER BC, FRIEDRICH T et al.: KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell (1999) 96(3):437-446.
- COX JJ, REIMANN F, NICHOLAS AK et al.: An SCN9A channelopathy causes congenital inability to experience pain. Nature (2006) 444(7121):894-898.
- HANNA MG: Genetic neurological channelopathies. Nat. Clin. Pract. Neurol. (2006) 2(5):252-263.
- VENANCE SL, CANNON SC, FIALHO D et al.: The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2006) 129(Pt. 1):8-17.
- WOLF CM, BERUL CI: Inherited conduction system abnormalities-one group of diseases, many genes. J. Cardiovasc. Electrophysiol. (2006) 17(4):446-455.
- MILJANICH GP: Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr. Med. Chem. (2004) 11(23):3029-3040.
- ASHTON H, YOUNG AH: GABA-ergic drugs: exit stage left, enter stage right. J. Psychopharmacol. (2003) 17(2):174-178.
- SANGUINETTI MC, TRISTANI-FIROUZI M: hERG potassium channels and cardiac arrhythmia. Nature (2006) 440(7083):463-469.
- SCHONHERR R: Clinical relevance of ion channels for diagnosis and therapy of cancer. J. Membr. Biol. (2005) 205(3):175-184.
- WULFF H, BEETON C, CHANDY KG: Potassium channels as therapeutic targets for autoimmune disorders. Curr. Opin. Drug Discov. Dev. (2003) 6(5):640-647.
- PRIEST B, KACZOROWSKI GJ, GARCIA ML: Ion channel modulators: new targets and new indications for old targets. Curr. Opin. Drug Discov. Dev. (2006) 9(5):587-594.
- LAWSON K, MCKAY NG: Modulation of potassium channels as a therapeutic approach. Curr. Pharm. Des. (2006) 12(4):459-470.
- SCHROEDER K, NEAGLE B, TREZISE DJ, WORLEY J: Ionworks HT: a new high-throughput electrophysiology measurement platform. J. Biomol. Screen. (2003) 8(1):50-64.
- HUANG CJ, HAROOTUNIAN A, MAHER MP et al.: Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential. Nat. Biotechnol. (2006) 24(4):439-446.
- HILLE B: Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J. Gen. Physiol. (1977) 69(4):497-515.